Conference Paper

Regenerative rotary displacer Stirling engine

Nihon Univ., Tokyo
DOI: 10.1109/IECEC.1996.553895 Conference: Energy Conversion Engineering Conference, 1996. IECEC 96. Proceedings of the 31st Intersociety, Volume: 2
Source: IEEE Xplore

ABSTRACT A few rotary displacer Stirling engines whose displacers have one
gas pocket space at one side, and rotate in a main enclosed cylinder,
which is heated from one side and cooled from the opposite side without
any regenerator have been tried and studied for a considerable time by
the authors. They then tried to improve this engine by equipping them
with regenerators, because without regenerators, pressure oscillation
and efficiency are insufficient. Here, several types of regenerative
rotary displacer piston Stirling engines are proposed. One is the
contra-rotating tandem two disc-type displacer engine, using axial heat
conduction through side walls or by heat pipes and the other are single
disc-types with circulating fluid regenerators or heat pipes. A
contra-rotating type engine has been manufactured and experimented upon
in order to assess the effect of the regenerators. Here, experimental
results of an original rotary displacer Stirling engine without a
regenerator and a contra-rotating tandem displacer engine with a side
wall regenerator using axial heat conduction are reported, accompanied
by many discussions

2 Bookmarks
 · 
271 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Members of the protein kinase C (PKC) family of serine/threonine kinases have been targeted for drug discovery for over 20 years, initially focusing on inhibitors of the classic PKCs, which include the alpha, beta and gamma isoforms. Recently, inhibition of the activity of the novel PKC isoforms, namely Theta, delta, epsilon and eta has become a focus of research. PKCTheta, first identified in 1992, is a key enzyme in the regulation of T cell activation and survival. While T cells play critical roles in initiating and controlling the immune response, inappropriate or extended stimulation of T cells is responsible for many chronic inflammatory diseases. Mice with an engineered deficiency in PKCTheta have reduced incidence and severity of several inflammatory disorders including asthma, arthritis, inflammatory bowel disease, multiple sclerosis, and allograft rejection. This review summarizes the efforts directed towards the design of small molecule PKCTheta inhibitors as potential therapeutic agents.
    Current topics in medicinal chemistry 02/2009; 9(7):640-54. · 4.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The amyloid beta-peptide (Abeta) activates microglia and promotes the generation of cytokines and oxygen species, including nitric oxide (NO) and tumor necrosis factor alpha (TNF-alpha), which can be either neurotoxic or neuroprotective. We show that neuron death in cocultures of rat cortical microglia and neurons activated by lipopolysaccharide (LPS) or Abeta1-42 plus interferon gamma (IFNgamma) is caused by short-lived diffusible molecules and follows the generation of superoxide and/or peroxynitrite as determined by electron paramagnetic spectroscopy. Neurotoxicity induced by LPS or Abeta1-42 plus IFNgamma is blocked by inhibitors of NO synthesis and by the peroxynitrite (ONOO-) decomposition catalysts FeTMPyP [5,10,15,20-tetrakis(n-methyl-4'-pyridyl)porphinato iron (III) chloride] and FeTPPS [5,10,15,20-tetrakis(4-sulfonatophenyl)prophyrinato iron (III) chloride] but not by the TNF-alpha inhibitor pentoxifylline. The specificity of FeTMPyP for ONOO- was confirmed by its ability to block the toxicity of a peroxynitrite donor but not of NO donors or of high levels of superoxide in a yeast mutant lacking superoxide dismutase 1. These results implicate peroxynitrite as a mediator of the toxicity of activated microglia, which may play a major role in Abeta1-42 neurotoxicity and Alzheimer's disease.
    Journal of Neuroscience 06/2002; 22(9):3484-92. · 6.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The controlling factors that prompt mature oligodendrocytes to myelinate axons are largely undetermined. In this study, we used a forward genetics approach to identify a mutant mouse strain characterized by the absence of CNS myelin despite the presence of abundant numbers of late-stage, process-extending oligodendrocytes. Through linkage mapping and complementation testing, we identified the mutation as a single nucleotide insertion in the gene encoding zinc finger protein 191 (Zfp191), which is a widely expressed, nuclear-localized protein that belongs to a family whose members contain both DNA-binding zinc finger domains and protein-protein-interacting SCAN domains. Zfp191 mutants express an array of myelin-related genes at significantly reduced levels, and our in vitro and in vivo data indicate that mutant ZFP191 acts in a cell-autonomous fashion to disrupt oligodendrocyte function. Therefore, this study demonstrates that ZFP191 is required for the myelinating function of differentiated oligodendrocytes.
    Genes & development 02/2010; 24(3):301-11. · 12.08 Impact Factor